An observed enrichment of RUNX2+ CD8+ cells (left-upper portion of T-helper/RUNX2_CD8 cluster) in MASLD could not be interpreted, as this population was primarily derived from a single patient. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.